O&G Forum

ENDOMETRIOSIS References: 1. Strowitzki T, Faustmann T, Gerlinger C, et al. Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. Int J Women’s Health 2015; 7: 393-401. 2. Ota H, Andou M, Yanai S, et al. Long-term administration of dienogest reduces recurrence after excision of endometrioma. J Endo and Pelvic Pain Disorders 2015; 7(2): 63-67. S3 Visanne ® Each tablet contains 2 mg dienogest. South African Reg. No.: 44/21.8.2/0159. Mauritius Reg. No.: PB/12884/05/2017. NS2 Visanne ® Namibia Reg. No.: 13/21.8.2/0230. Zimbabwe Reg. No.: 2017/21.8/5493 Bayer (Pty) Ltd, Reg. No.:1968/011192/07. 27 Wrench Road, Isando, South Africa, 1609. Tel: +27 (0)11 921 5040. For full prescribing information, refer to the Professional Information approved by the medicines regulatory authority. PP-VIS-ZA-0027-1 There is a way out of the pain. Significant reduction in pain intensity 1 Significant efficacy for lesion reduction 1 Proven reduction of post- operative recurrence 2 Favourable safety and tolerability profile 1 Visanne @ offers: